Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Emerging evidence indicates that adipose stromal cells (ASC) are recruited to enhance cancer development. In this study, we examined the role these adipocyte progenitors play relating to intercellular communication in obesity-associated
endometrial cancer
. This is particularly relevant given that gap junctions have been implicated in tumor suppression. Examining the effects of ASCs on the transcriptome of endometrial epithelial cells (EEC) in an
in vitro
coculture system revealed transcriptional repression of
GJA1
(encoding the gap junction protein Cx43) and other genes related to intercellular communication. This repression was recapitulated in an obesity mouse model of
endometrial cancer
. Furthermore, inhibition of plasminogen activator inhibitor 1 (PAI-1), which was the most abundant ASC adipokine, led to reversal of cellular distribution associated with the
GJA1
repression profile, suggesting that PAI-1 may mediate actions of ASC on transcriptional regulation in EEC. In an
endometrial cancer
cohort (
n
= 141), DNA hypermethylation of
GJA1
and related loci
TJP2
and
PRKCA
was observed in primary endometrial endometrioid tumors and was associated with obesity. Pharmacologic reversal of DNA methylation enhanced gap-junction intercellular communication and cell-cell interactions
in vitro
. Restoring Cx43 expression in
endometrial cancer
cells reduced cellular migration; conversely, depletion of Cx43 increased cell migration in immortalized normal EEC. Our data suggest that persistent repression by ASC adipokines leads to promoter hypermethylation of
GJA1
and related genes in the endometrium, triggering long-term silencing of these loci in endometrial tumors of obese patients. SIGNIFICANCE: Studies reveal that adipose-derived stem cells in
endometrial cancer
pathogenesis influence epigenetic repression of gap junction loci, which suggests targeting of gap junction activity as a preventive strategy for obesity-associated
endometrial cancer
.
...
PMID:Adipokines Deregulate Cellular Communication via Epigenetic Repression of
Gap Junction
Loci in Obese Endometrial Cancer. 3038 2
Endometrial cancer
develops as a result of abnormal cell growth associated with uncontrolled cell proliferation, excessive activation of signaling pathways and miRNA activity. The aim of this study was to determine the expression profile of genes associated with cell proliferation and to assess which miRNAs can participate in the regulation of their expression. The study enrolled 40 patients with
endometrial cancer
and 10 patients without neoplastic changes. The expression profile of genes associated with cell proliferation and the expression profile of miRNAs were assessed using microarrays. RT-qPCR was performed to validate mRNA microarray results. The mirTAR tool was used to identify miRNAs that regulate the activity of genes associated with cell proliferation. Decreased expression of
IGF1
and
MYLK
, as well as
SOD2
overexpression, were observed in
endometrial cancer
using both mRNA microarrays and RT-qPCR. Microarray analysis showed low levels of
NES
and
PRKCA
, but this was only partially validated using RT-qPCR. Reduced activity of
MYLK
may be caused by increased miR-200c, miR-155 and miR-200b expression. Cell proliferation is disturbed in
endometrial cancer
, which may be associated with an overexpression of miR-200a, miR-200c, and miR-155, making it a potential diagnostic marker.
...
PMID:Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer. 3179 19